According to the desmoglein (Dsg) compensation concept, different epidermal cleavage planes observed in pemphigus vulgaris and pemphigus foliaceus have been proposed to be caused by different autoantibody profiles against the desmosomal proteins Dsg 1 and Dsg 3. According to this model, Dsg 1 autoantibodies would only lead to epidermal splitting in those epidermal layers in which no Dsg 3 is present to compensate for the functional loss of Dsg 1. We provide evidence that both pemphigus foliaceus-IgG containing Dsg 1-but not Dsg 3-specific antibodies and pemphigus vulgaris-IgG with antibodies to Dsg 1 and Dsg 3 were equally effective in causing epidermal splitting in human skin and keratinocyte dissociation in vitro. These effects were present where keratinocytes expressed both Dsg 1 and Dsg 3, demonstrating that Dsg 3 does not compensate for Dsg 1 inactivation. Rather, the cleavage plane in intact human skin caused by pemphigus autoantibodies was similar to the plane of keratinocyte dissociation in response to toxin B-mediated inactivation of Rho GTPases. Because we recently demonstrated that pemphigus-IgG causes epidermal splitting by inhibition of Rho A, we propose that Rho GTPase inactivation contributes to the mechanisms accounting for the cleavage plane in pemphigus skin splitting. Pemphigus is an autoimmune blistering skin disease caused by autoantibodies directed to the cadherin-type adhesion molecules desmoglein (Dsg) 1 and 3.1-4 Antibodies against other antigens, including cholinergic receptors, have also been implicated in the pathogenesis.5-9 Several theories have been proposed to explain the mechanisms underlying blister formation by Dsg autoantibodies. However, the different clinical phenotypes of pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are still not fully understood. 10 -12 It is well established that PV is characterized by deep (suprabasal) epidermal blistering, whereas PF exhibits superficial blistering (involving granular or spinous cell layers). In PF, mucous membranes are not involved; whereas in PV, mucosal disease is a regular finding, and skin involvement may occur in addition. 4 Interestingly, these phenotypes usually correlate with different autoantibody profiles. PV patients with only mucosal lesions show autoantibodies to Dsg 3 but not to Dsg 1. PF patients (skin involvement only) reveal autoantibodies to Dsg 1 but not to Dsg 3. In PV patients with both mucous membrane and skin involvement, autoantibodies to Dsg 3 and Dsg 1 may be detected. 4,13,14 These observations, together with studies reporting that Dsg 1 is predominantly expressed in superficial epidermal layers but absent in the suprabasal layer, whereas Dsg 3 is restricted to deep epidermal layers, and that Dsg 1 is less abundantly expressed in mucosal epithelia, have led to the desmoglein compensation hypothesis as an explanation for the different epidermal cleavage planes in PV and PF. 3,4,[15][16][17] According to this model, in the deep epidermis, Dsg 3 compensates for the functional loss of Dsg 1 induced by Ds...